On September 30, 2026, the Third Circuit issued its decision in In re Ocugen Inc. Securities Litigation, partially abrogating a nearly 30-year line of circuit precedent that treated an issuer’s stock-price response to a corrective disclosure as dispositive of materiality.
The court held that materiality must instead be assessed under the Supreme Court’s fact-specific “total mix” standard reaffirmed in Matrixx. Although the ruling blunts a potentially powerful pleading-stage defense in the Third Circuit, it also provides more specific guidance for assessing materiality.
Background
Investors brought a putative securities class action against Ocugen Inc. and its chief executive officer, alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act and Rule 10b-5. The complaint challenged company statements involving a collaboration agreement, disclosures surrounding the departure of Ocugen’s chief financial officer (CFO), and the delayed filing of its second-quarter 2023 Form 10-Q with the Securities and Exchange Commission.
Ocugen ultimately announced that it would restate 15 quarters of financial statements and disclosed a material weakness in its internal control over financial reporting. Its stock declined approximately 10% the next trading day but recovered to its pre-disclosure level over the next two trading days. The investors filed suit nine days after the price decline.
The defendants moved to dismiss, relying on the Third Circuit's decisions in In re Burlington Coat Factory Securities Litigation and Oran v. Stafford. Those cases established a categorical materiality rule based on a company’s stock-price movement following a corrective disclosure.
Under that rule, an alleged misrepresentation was immaterial as a matter of law if the corrective disclosure had only a negligible effect on the company's stock price. Applying the Oran-Burlington rule, the defendants argued that the company’s complete stock-price recovery within two trading days conclusively established that the alleged misrepresentations were immaterial.
The district court dismissed the amended complaint with prejudice. It held that certain August 2023 disclosures were not actionably misleading because the plaintiffs had not alleged a duty to disclose the circumstances surrounding the CFO’s departure. Citing Oran and Burlington, the district court also held that the company’s rapid stock-price recovery demonstrated the April 2024 restatement disclosure was immaterial as a matter of law.
Third Circuit Rejects a Categorical Stock-Price Rule
The Third Circuit agreed that certain August 2023 statements were not actionable but reversed the district court’s dismissal of the remaining challenged statements on materiality grounds. The panel held that the Supreme Court's decision in Matrixx Initiatives Inc. v. Siracusano could not be reconciled with a categorical rule under which a negligible stock-price response or a rapid rebound conclusively established immateriality.
Under the governing standard, courts must determine whether there is a substantial likelihood that the omitted or misstated information would have significantly altered the “total mix” of information available to a reasonable investor at the time of the investment decision.
The Third Circuit emphasized that this inquiry is distinct from loss causation, which considers whether a disclosure revealed the alleged fraud and caused the asserted loss. Materiality instead focuses on whether the issuer’s challenged statements would have been significant to investors when deciding whether to trade.
The court therefore partially abrogated the portions of Burlington and Oran that developed or applied the categorical stock-price rule. It vacated the district court’s judgment and remanded for the court to assess the challenged statements’ falsity and materiality and, if necessary, scienter. The panel also vacated the dismissal of the Section 20(a) claim and directed the district court to consider whether leave to amend was appropriate.
Court Clarifies the Significance of “Big R” Restatements
The Third Circuit declined to replace one categorical rule with another, specifically cautioning against a rule “that restatements always render some prior disclosures materially false.”
The court clarified that a “Big R” restatement—one in which a company finds a material error and must restate and reissue its financial statements—does not automatically establish that prior disclosures were materially false or misleading. Courts must examine what the restatement changed and whether those changes would have significantly altered the total mix of information available to a reasonable investor.
In Ocugen, the panel further illustrated why a “Big R” restatement alone may not establish materiality. Although the complaint alleged that changes to the company’s restated financial figures exceeded 35% for 2022 and 2023, it alleged “very little” about the restatement’s significance for the 2020 and 2021 financial statements.
The panel therefore instructed the district court on remand to “probe the ‘total mix’ of information available to reasonable investors” to assess what exactly the restatement revealed about the company’s prior disclosures.
Practical Takeaways
Ocugen eliminates a defendant-friendly rule that had allowed courts in the Third Circuit to treat a muted market response or rapid stock-price recovery as dispositive of materiality.
The decision aligns the Third Circuit with other circuits that have rejected categorical stock-price-based materiality rules. The Ninth Circuit, for example, previously declined to adopt the Oran-Burlington rule, reasoning that market reaction is relevant but not determinative. The Second Circuit likewise has recognized that a stock’s price movement, or lack of movement, does not determine whether information is material.
These cases reaffirm the fact-specific inquiry required by the Supreme Court's decision in Matrixx. They do not, however, eliminate all materiality defenses, leaving defendants with other avenues to challenge that element in securities fraud class actions.
If you have any questions, or would like additional information, please contact one of the attorneys on our Securities Litigation team.
You can subscribe to future advisories and other Alston & Bird publications by completing our publications subscription form.